Showing results (41-50 of 104) with videos related to
Sort By:
Pageof 11
Cancer Letters|February 21, 2021
Caveolin-1 promotes radioresistance in rhabdomyosarcoma through increased oxidative stress protection and DNA repairSilvia Codenotti, Francesco Marampon, Luca Triggiani, et al.Advances in Radiation Oncology|February 6, 2025
Impact of the Number of Administered Systemic Treatment Lines on Local Response to Radiation Therapy for Multiple MyelomaAndrea Emanuele Guerini, Eneida Mataj, Paolo Borghetti, et al.Journal of Clinical Medicine|June 19, 2024
SBRT in Lymph-Nodal Oligometastases from Prostate Cancer: Different Outcomes between Pelvic and Para-Aortic DiseaseEdoardo Pastorello, Luca Nicosia, Luca Triggiani, et al.Critical Reviews in Oncology/Hematology|May 17, 2019
Consensus statements on ablative radiotherapy for oligometastatic prostate cancer: A position paper of Italian Association of Radiotherapy and Clinical Oncology (AIRO)Rolando M D'Angelillo, Giulio Francolini, Gianluca Ingrosso, et al.Journal of Neurosurgical Sciences|September 30, 2016
Second line treatment of recurrent glioblastoma with sunitinib: results of a phase II study and systematic review of literatureSalvatore Grisanti, Vittorio D Ferrari, Michela Buglione, et al.Practical Radiation Oncology|November 3, 2024
Management of de Novo Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) and the Role of Radiation Therapy: A Consensus by the Italian Association of Radiotherapy and Clinical Oncology (AIRO)Andrea Lancia, Anna Rita Alitto, Giovanni Pappagallo, et al.Medical Oncology (Northwood, London, England)|March 24, 2021
OLIGO-AIRO: a national survey on the role of radiation oncologist in the management of OLIGO-metastatic patients on the behalf of AIRORosario Mazzola, Barbara Alicja Jereczek-Fossa, Paolo Antognoni, et al.Clinical and Translational Radiation Oncology|April 15, 2025
Adaptive radiotherapy for oropharyngeal cancer with daily adapt-to-shape workflow on 1.5 T MRI-linac: Preliminary outcomes and comparison with helical tomotherapyAndrea Emanuele Guerini, Michela Buglione, Stefania Nici, et al.Cancers|March 13, 2025
Real-World Insights into the Impact of Durvalumab on Stage III Unresectable Non-Small Cell Lung Cancer-A Narrative ReviewGiorgio Facheris, Gianluca Cossali, Jessica Imbrescia, et al.Hematology Reports|April 25, 2025
Treatment of Non-Hodgkin Lymphoma Involving Head and Neck Sites with a 1.5 T MR-Linac: Preliminary Results from a Prospective Observational StudyAndrea Emanuele Guerini, Stefania Nici, Stefano Riga, et al.Pageof 11